Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. - sprookjes - yvandenbroek - TriplyDB

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

http://www.wikidata.org/entity/Q33912750

about

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials Long-term course and effectiveness of combination therapy in Alzheimer disease Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors Assessment and management of behavioral and psychological symptoms of dementia Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.Cholinesterase inhibitors: drugs looking for a disease?Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.Evidence-based ethics--what it should be and what it shouldn't.Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients.Update on the pharmacological treatment of Alzheimer's disease The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial.Blockade of GABA(B) receptors completely reverses age-related learning impairment.Study of Mental Activity and Regular Training (SMART) in at risk individuals: a randomised double blind, sham controlled, longitudinal trial The Effects of Melilotus officinalis Extract on Expression of Daxx, Nfkb and Vegf Genes in the Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding Therapy for Alzheimer's Disease: How Effective are Current Treatments?Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.Naturally occurring multipotent anti-Alzheimer's agents.The impact of Medicare prescription drug coverage on the use of antidementia drugs.Does analysis using "last observation carried forward" introduce bias in dementia research?Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.The role of nutrition in Alzheimer's disease: epidemiological evidence.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's disease.Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers.Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI.Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease.Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers Treatment of dementia

P2860

Q21092367-1D61F96F-BEDB-4120-9D03-37E8705DECF6 Q24642161-B85AD8BF-81AD-4350-8BA1-A466C27CC95D Q26997299-21F6B4C4-4210-496B-979A-92CCEA69E2BA Q28088782-C383A580-B24E-4F28-8634-8A1FEECE6ECE Q28547651-44E36CC4-1F1E-4180-808A-B154CD07D928 Q30477103-1D7DF5DA-D22D-4354-8347-3F242E8B0CC1 Q30833736-2E08CEE8-3A5C-477C-BF54-68B20622A34A Q33238993-BAC5B508-005F-4AFB-8487-138E4C039F2E Q33289262-851E326D-65DB-468A-BD16-54641D2351F9 Q33378223-4737268A-DFB0-4175-96C7-A6CC0AF36530 Q33393907-557F2AEF-3C95-4F03-9493-FAD5F5EC1976 Q33454879-454DC3B4-1A5F-4205-AC5C-6FA293EBCEAA Q33586027-AC82DF9B-22E1-492A-B0A9-CEC709B19A58 Q33736233-F2B5675C-093F-4359-8594-260D30A692C5 Q33836947-2FEA95B9-C168-4D55-935B-952C74F818E8 Q33869501-45AE5D0A-3EB1-4B79-8DC0-57A5E3E6EFB4 Q33870626-C6A15F9D-A565-4C5D-8A25-5365494A4065 Q33879103-D8A4DCEF-EFBF-454F-BE47-CDC04881F7B6 Q33883027-6151F812-8413-4132-80D0-A936B3CB8E69 Q34162212-6A6B2818-3145-440F-8B79-1A1A3C1C1AFF Q34222721-17CD641E-B9FC-46CE-B1F9-A41D6DCA3EE3 Q34361691-3726F958-4C05-45ED-A322-E4792ABFB278 Q34409349-1346E430-1EC2-49D8-8719-D2FFFE8B8CEB Q34418562-98525832-B60A-4A51-B391-AA26E94F2594 Q34528182-55DF2018-D0F0-4069-80B6-236DF7903636 Q34533560-761ADC9C-0E6F-41CE-9F47-329E9BADA3AF Q34621248-C137A6F4-7F7F-4DF2-A6E6-C4C96CADA17A Q34690333-D6F1A3DC-FEE1-4974-853C-DE97F12B6C28 Q34846882-6C68E28A-86E8-4723-9759-FD5B62ADDF69 Q34965949-EB23B977-A592-43BD-AD69-24122C572B65 Q34987695-8E77F206-BA26-413C-98DD-8FF13BF8935B Q34999138-BE8DF4E9-6503-4EF0-8C4C-7BF9B26DD9FF Q35016920-F31F5B53-E106-4889-A386-2335B4728410 Q35135672-09B5DCF3-9457-42CF-999D-55501C2E2CF8 Q35210016-9D430532-438F-4384-8EEB-C5B1E89D63C5 Q35210180-55A57BD6-0896-48ED-BD18-860BBA3E38EF Q35223905-DE5DDDB9-C07C-4ACF-A24C-3E9F7F09A7FC Q35539649-DE120B79-ED89-4837-8A0A-78E069BD80D0 Q35561661-32460B5B-78A8-402F-9605-9AE4A53B62C4 Q35576634-33E0EEE8-BE75-4D64-B9E5-9644A1D04AF7

P2860

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

http://www.wikidata.org/entity/Q33912750

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cholinesterase inhibitors for ...... of randomised clinical trials.

@ast

Cholinesterase inhibitors for ...... of randomised clinical trials.

@en

type

label

Cholinesterase inhibitors for ...... of randomised clinical trials.

@ast

Cholinesterase inhibitors for ...... of randomised clinical trials.

@en

prefLabel

Cholinesterase inhibitors for ...... of randomised clinical trials.

@ast

Cholinesterase inhibitors for ...... of randomised clinical trials.

@en

P1433

Q33912750-9FAD8346-6B3F-4B4D-96D6-DD33BD0F2A26

P1476

Q33912750-D659E5C3-5FA1-4F53-916E-CBCBEA13EAC8

P2093

Q33912750-3DAA9F3F-02FC-4B5B-B04B-ECCEF3A51A45

Q33912750-5643CAC9-111D-4B17-B066-D72D5D57EE83

Q33912750-EF9FAFBF-CE08-4305-8221-6A9ACF171FF7

P2860

Q33912750-0A3CAA99-610E-4B0F-892F-D9F441A102C0

Q33912750-0BF0F479-C761-4D3F-A852-6A05CF6A307B

Q33912750-0C5C87BF-4EDB-4205-B6D0-54DE09147BDF

Q33912750-0D31CCF6-B019-4355-89CC-54D173F79810

Q33912750-123C8F8B-A9F1-46EE-8A02-C6393B00B61B

Q33912750-1EAAE61D-4365-4485-B792-CA45D5B489E8

Q33912750-1F5F7BFE-4DFC-448A-81A1-0BA877CAF85F

Q33912750-2DA73BA4-4EE5-4A49-A57B-0FFBB26323CD

Q33912750-2ED35307-1B36-4538-B602-09E316387378

Q33912750-30B58ECB-E1F9-42D7-BDEF-BC197D4EFB29

P304

Q33912750-23A1A623-D273-43A5-8AB3-6A520B915A4C

P31

Q33912750-25c8917b-447d-4586-b2d5-93418ad6dee5

Q33912750-A2506211-FA5E-4E36-A7DF-7EB186B2BAAA

P356

Q33912750-73CB842E-19F8-4D6A-A0DC-DD2A95560CD9

P407

Q33912750-49A262BF-71B4-46D6-AE79-7AECEB65DB53

P433

Q33912750-969ED89E-47B7-48A6-AC56-4C7D1A06B837

P478

Q33912750-06A931D9-D3D8-4CB2-A06C-70F6FC802275

P50

Q33912750-43971CE8-F396-43DD-B23B-043EEBE989DF

P577

Q33912750-2A015001-125A-4AE5-AFDC-FF19F9963E50

P5875

Q33912750-5B9E230F-1D85-4C03-B3F1-09BFF190E82A

P698

Q33912750-F524F542-35C1-42B2-95CC-D7B79931E620

P921

Q33912750-ED276B41-1583-4B18-BE65-3BB9746A855E

P932

Q33912750-01196D11-13DF-47CF-98BF-92787E7F9351

P356

BMJ.331.7512.321

P1433

P1476

Cholinesterase inhibitors for ...... of randomised clinical trials.

@en

P2093

Hans-Peter Beck-Bornholdt

http://www.w3.org/2001/XMLSchema#string

Hendrik van den Bussche

http://www.w3.org/2001/XMLSchema#string

Thomas Zimmermann

http://www.w3.org/2001/XMLSchema#string

P2860

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

Donepezil for dementia due to Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Donepezil therapy in clinical practice: a randomized crossover study.

Rivastigmine for Alzheimer's disease.

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials.

P304

321-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.331.7512.321

http://www.w3.org/2001/XMLSchema#string

P407

P433

7512

http://www.w3.org/2001/XMLSchema#string

P478

331

http://www.w3.org/2001/XMLSchema#string

P50

Hanna Kaduszkiewicz

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7679514

http://www.w3.org/2001/XMLSchema#string

P698

16081444

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1183129

http://www.w3.org/2001/XMLSchema#string